Actinium Makes New Appointments
This article was originally published in Scrip
Actinium Pharmaceuticals, Inc. has appointed Kevin Zikaras senior clinical scientist and Rowena Choudrie senior director, pharmaceutical product development. Zikaras joins Actinium from Bristol-Myers Squibb where he was clinical protocol manager in the immuno-oncology group and prior to this he was clinical research manager at Columbia University Medical Center. Choudrie has over 20 years' experience in the pharma industry and most recently was senior director, pharma development, global technical operations at NPS Pharmaceuticals. Previously, she worked at Palatin Technologies, Inc. as director, formulation development and manufacturing.